POSB111 Projected Health Outcomes with Real-World Versus Optimal Usage of Sacubitril/Valsartan in Portugal

Abstract

Authors

M Pardal M Machado T Guerreiro M Afonso-Silva

Full Text Cite This Article
Back to ISPOR Europe 2021 Abstracts: Emerging Frontiers and Opportunities
Your browser is out-of-date

ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now

×